Introduction
This anonymous survey, conducted by the Menopause Society of Ireland (MSI), is part of a patient experience submission to the National Centre for Pharmacoeconomics (NCPE) for a Health Technology Assessment (HTA). Participation is voluntary. No identifying information about you or your patients will be collected. Responses will be analysed in aggregate and may be summarised in the submission.
This survey gathers your observations on patient feedback of the management of vasomotor symptoms (VMS) — including hot flushes, night sweats, and difficulty regulating body temperature — and your experience with fezolinetant (Veoza™), if prescribed.
Please do not include any identifiable patient or clinic details. Data will be stored securely and accessed only by the Menopause Society of Ireland for the purpose described above